Human type IIIL-1β decoy receptor:: Potential for gene therapy in arthritis

被引：0
|
作者：
Amin, AR
Attur, MG
Dave, MN
Cipolletta, C
Woo, SLC
Meseck, M
Abramson, SB
机构：
[1] Hosp Joint Dis & Med Ctr, New York, NY 10003 USA
[2] CUNY Mt Sinai Sch Med, New York, NY 10029 USA
来源：
FASEB JOURNAL | 2001年 / 15卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A695 / A695
页数：1
相关论文
共 50 条
  • [21] Arthritis Gene Therapy Using Interleukin-1 Receptor Antagonist
    Evans, Christopher
    ARTHRITIS & RHEUMATOLOGY, 2018, 70 (11) : 1699 - 1701
  • [22] Gene therapy with transcription factor decoy oligonucleotides as a potential treatment for cardiovascular diseases
    Tomita, N
    Azuma, H
    Kaneda, Y
    Ogihara, T
    Morishita, R
    CURRENT DRUG TARGETS, 2003, 4 (04) : 339 - 346
  • [23] Cis element 'decoy' against the upstream promoter of the human estrogen receptor gene
    Penolazzi, L
    Lambertini, E
    Aguiari, G
    del Senno, L
    Piva, R
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2000, 1492 (2-3): : 560 - 567
  • [24] Selectivity release of the type II decoy IL-1 receptor
    Orlando, S
    Polentarutti, N
    Mantovani, A
    CYTOKINE, 2000, 12 (07) : 1001 - 1006
  • [25] THE TYPE-II RECEPTOR AS A DECOY TARGET FOR INTERLEUKIN-1
    RE, F
    COLOTTA, F
    MUZIO, M
    POLENTARUTTI, N
    SIMS, JE
    DOWER, SK
    GIRI, JG
    MANTOVANI, A
    JOURNAL OF LEUKOCYTE BIOLOGY, 1993, : 51 - 51
  • [26] Dopamine receptor modulation on osteoblast as a potential therapy for arthritis
    Tejedor, L. Salinas
    Rickert, M.
    Steinmeyer, J.
    Rehart, S.
    Neumann, E.
    Harre, U.
    Schett, G.
    Mueller-Ladner, U.
    Capellino, S.
    BRAIN BEHAVIOR AND IMMUNITY, 2019, 76 : E17 - E18
  • [27] Role of metalloproteases in the release of the IL-1 type II decoy receptor
    Orlando, S
    Sironi, M
    Bianchi, G
    Drummond, AH
    Boraschi, D
    Yabes, D
    Mantovani, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (50) : 31764 - 31769
  • [28] CHEMOATTRACTANTS INDUCE RAPID RELEASE OF THE INTERLEUKIN-1 TYPE-II DECOY RECEPTOR IN HUMAN POLYMORPHONUCLEAR CELLS
    COLOTTA, F
    ORLANDO, S
    FADLON, EJ
    SOZZANI, S
    MATTEUCCI, C
    MANTOVANI, A
    JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (06): : 2181 - 2188
  • [29] The potential of gene therapy for mucopolysaccharidosis type I
    Pimentel Vera, Luisa Natalia
    Baldo, Guilherme
    EXPERT OPINION ON ORPHAN DRUGS, 2020, 8 (01): : 33 - 41
  • [30] Human type-1 angiotensin II (AT(1)) receptor gene structure and function
    Curnow, KM
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1996, 23 : S67 - S73
12345